No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma

Annette Juul Vangsted, Karen Søeby, Tobias W Klausen, Niels Abildgaard, Niels F Andersen, Peter Gimsing, Henrik Gregersen, Ulla Vogel, Thomas Werge, Henrik B Rasmussen

Research output: Contribution to journal › Journal article › Research › peer-review

22 Citations (Scopus)

Fingerprint

Dive into the research topics of 'No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma'. Together they form a unique fingerprint.

Immunology and Microbiology